Headquartered in Riyadh, Saudi Arabia, LAFANA Holding is a leading investment company with a focus on delivering value, building partnerships, and driving growth across multiple asset classes. Committed to high ethical standards and operational excellence, LAFANA integrates specialist expertise to develop business strategies that benefit shareholders, partners, and the community. Aspiring to become a key player in cell and gene therapy in the Middle East, LAFANA supports precision medicine through research, manufacturing, and services in genomic medicine. Aligned with Saudi Vision 2030, LAFANA is dedicated to advancing biotechnology, particularly for diseases with unmet needs, by localizing capabilities and fostering national expertise to serve local, regional, and international markets.